Deutsch English Français

Contact

EP1404676

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1404676

EP1404676 - PYRROLOPYRIMIDINES AS PROTEIN KINASE INHIBITORS [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 21.02.2014 Database last updated on 14.09.2024
Most recent event Tooltip	21.02.2014	Application deemed to be withdrawn	published on 26.03.2014 [2014/13]
Applicant(s)	For all designated states Aventis Pharmaceuticals Inc. 300 Somerset Corporate Boulevard Bridgewater, New Jersey 08807 / US
	[N/P]
Former [2004/15]	For all designated states AVENTIS PHARMACEUTICALS INC. 300 Somerset Corporate Boulevard Bridgewater, New Jersey 08807 / US
Inventor(s)	01 / COX, Paul Joseph 238 Skyline Drive Millington, NJ 07946 / US
	02 / MAJID, Tahir Nadeem 77 Park Avenue 1511 Hoboken, NJ 07030 / US
	03 / AMENDOLA, Shelley 271 Thistle Lane Bedminster, NJ 07921 / US
	04 / DEPRETS, Stephanie Daniele 43 Ford Avenue, Unit 9 Morristown, NJ 07960 / US
	05 / EDLIN, Chris 19 Garden Row Hitchin, Herts SG5 1QD / GB
	06 / PEDGRIFT, Brian Leslie, Aventis Pharma Limited Aventis House 50 Kings Hill Avenue Kings Hill West Malling, Kent ME19 4AH / GB
	07 / HALLEY, Frank, Aventis Pharma Limited Aventis House 50 Kings Hill Avenue Kings Hill West Malling, Kent ME19 4AH / GB
	08 / EDWARDS, Michael, Aventis Pharma Limited Aventis House 50 Kings Hill Avenue Kings Hill West Malling, Kent ME19 4AH / GB
	09 / BAUDOIN, Bernard, Aventis Pharma Limited Adventis House 50 Kings Hill Avenue Kings Hill West Malling, Kent ME19 4AH / GB
	10 / McLAY, Iain McFarlane 9, Sutton Close Loughton, Essex IG 10 3DP / GB
	11 / ALDOUS, Davis John, Aventis Pharma Limited Aventis House 50 Kings Hill Avenue Kings Hill West Malling, Kent ME19 4AH / GB
	[2013/24]
Former [2007/32]	01 / COX, Paul Joseph 238 Skyline Drive Millington, NJ 07946 / US
	02 / MAJID, Tahir Nadeem 77 Park Avenue 1511 Hoboken, NJ 07030 / US
	03 / AMENDOLA, Shelley 271 Thistle Lane Bedminster, NJ 07921 / US
	04 / DEPRETS, Stephanie Daniele 43 Ford Avenue, Unit 9 Morristown, NJ 07960 / US
	05 / EDLIN, Chris 19 Garden Row Hitchin, Herts SG5 1QD / GB
	06 / PEDGRIFT, Brian Leslie, Aventis Pharma Limited Aventis House, 50 Kings Hill Avenue, Kings Hill West Malling, Kent ME19 4AH / GB
	07 / HALLEY, Frank, Aventis Pharma Limited Aventis House, 50 Kings Hill Avenue, Kings Hill West Malling, Kent ME19 4AH / GB
	08 / EDWARDS, Michael, Aventis Pharma Limited Aventis House, 50 Kings Hill Avenue, Kings Hill West Malling, Kent ME19 4AH / GB
	09 / BAUDOIN, Bernard, Aventis Pharma Limited Adventis House, 50 Kings Hill Avenue, Kings Hill West Mall ing, Kent ME19 4AH / GB
	10 / McLAY, Iain McFarlane 9, Sutton Close Loughton, Essex IG 10 3DP / GB
	11 / ALDOUS, Davis John, Aventis Pharma Limited Aventis House, 50 Kings Hill Avenue Kings Hill West Malling, Kent ME19 4AH / GB
Former [2004/20]	01 / COX, Paul Joseph 238 Skyline Drive Millington, NJ 07946 / US
	02 / MAJID, Tahir Nadeem 77 Park Avenue #1511 Hoboken, NJ 07030 / US
	03 / AMENDOLA, Shelley 271 Thistle Lane Bedminster, NJ 07921 / US
	04 / DEPRETS, Stephanie Daniele 43 Ford Avenue, Unit 9 Morristown, NJ 07960 / US
	05 / EDLIN, Chris 19 Garden Row Hitchin, Herts SG5 1QD / GB
	06 / PEDGRIFT, Brian Leslie, Aventis Pharma Limited Aventis House, 50 Kings Hill Avenue, Kings Hill West Malling, Kent ME19 4AH / GB
	07 / HALLEY, Frank, Aventis Pharma Limited Aventis House, 50 Kings Hill Avenue, Kings Hill West Malling, Kent ME19 4AH / GB
	08 / EDWARDS, Michael, Aventis Pharma Limited Aventis House, 50 Kings Hill Avenue, Kings Hill West Malling, Kent ME19 4AH / GB
	09 / BAUDOIN, Bernard, Aventis Pharma Limited Adventis House, 50 Kings Hill Avenue, Kings Hill West Mall ing, Kent ME19 4AH / GB
	10 / McLAY, Iain McFarlane 9, Sutton Close Loughton, Essex IG 10 3DP / GB
	11 / ALDOUS, Davis John, Aventis Pharma Limited Aventis House, 50 Kings Hill Avenue Kings Hill West Malling, Kent ME19 4AH / GB
Former [2004/15]	01 / COX, Paul Joseph, Aventis Pharma Ltd. Aventis Hous, 50 Kings Hill Avenue West Malling, Kent ME19 4AH / GB
	02 / MAJID, Tahir Nadeem, Aventis Pharma Limited Aventis House, 50 Kings Hill Avenue Kings Hill, West Malling, Kent ME 19 4AH / GB
	03 / AMENDOLA, Shelley 271 Thistle Lane Bedminster, NJ 07921 / US
	04 / DEPRETS, Stephanie Daniele, Aventis Pharma Limited Aventis House, 50 Kings Hill Avenue, Kings Hill West Malling, Kent ME19 4AH / GB
	05 / EDLIN, Chris, Aventis Pharma Limited Aventis House, 50 Kings Hill Avenue West Malling, Kent ME19 4AH / GB
	06 / PEDGRIFT, Brian Leslie, Aventis Pharma Limited Aventis House, 50 Kings Hill Avenue, Kings Hill West Malling, Kent ME19 4AH / GB
	07 / HALLEY, Frank, Aventis Pharma Limited Aventis House, 50 Kings Hill Avenue, Kings Hill West Malling, Kent ME19 4AH / GB
	08 / EDWARDS, Michael, Aventis Pharma Limited Aventis House, 50 Kings Hill Avenue, Kings Hill West Malling, Kent ME19 4AH / GB
	09 / BAUDOIN, Bernard, Aventis Pharma Limited Adventis House, 50 Kings Hill Avenue, Kings Hill West Mall ing, Kent ME19 4AH / GB
	10 / McLAY, Iain McFarlane 9, Sutton Close Loughton, Essex IG 10 3DP / GB
	11 / ALDOUS, Davis John, Aventis Pharma Limited Aventis House, 50 Kings Hill Avenue Kings Hill West Malling, Kent ME19 4AH / GB
Representative(s)	Then, Johann Sanofi-Aventis Deutschland GmbH Global Intellectual Property Department Industriepark Höchst Gebäude K 703 65926 Frankfurt am Main / DE
	[N/P]
Former [2004/15]	Then, Johann, Dr. Aventis Pharma Deutschland GmbH Patent- und Lizenzabteilung Gebäude K 801 65926 Frankfurt am Main / DE
Application number, filing date	02740895.4	21.06.2002
	[2004/15]
	WO2002GB02835
Priority number, date	GB20010015393	23.06.2001 Original published format: GB 0115393
	US20010301678P	28.06.2001 Original published format: US 301678 P
	[2004/15]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO03000695
	Date:	03.01.2003
	Language:	EN
	[2003/01]
	Type:	A1 Application with search report
	No.:	EP1404676
	Date:	07.04.2004
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 03.01.2003 takes the place of the publication of the European patent application.
	[2004/15]
Search report(s)	International search report - published on:	EP	03.01.2003
Classification	IPC:	C07D487/04, A61K31/505, A61P29/00	[2004/15]
	CPC:	C07D487/04 (EP); A61P11/00 (EP); A61P11/02 (EP); A61P11/06 (EP); A61P17/00 (EP); A61P17/06 (EP); (+) A61P19/02 (EP); A61P27/14 (EP); A61P29/00 (EP); A61P35/00 (EP); A61P37/08 (EP); A61P43/00 (EP); A61P9/00 (EP) (-)
Designated contracting states	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2004/15]
Extension states	AL	Not yet paid
	LT	Not yet paid
	LV	Not yet paid
	MK	Not yet paid
	RO	Not yet paid
	SI	Not yet paid
Title	German:	PYRROLOPYRIMIDINE ALS PROTEINKINASEHEMMER	[2004/15]
	English:	PYRROLOPYRIMIDINES AS PROTEIN KINASE INHIBITORS	[2004/15]
	French:	PYRROLOPYRIMIDINES UTILISEES EN TANT QU'INHIBITEURS DES PROTEINES KINASES	[2004/15]
Entry into regional phase	23.01.2004	National basic fee paid
	23.01.2004	Designation fee(s) paid
	23.01.2004	Examination fee paid
Examination procedure	04.10.2002	Request for preliminary examination filed International Preliminary Examining Authority: EP
	23.01.2004	Examination requested [2004/15]
	21.07.2008	Despatch of a communication from the examining division (Time limit: M06)
	14.01.2009	Reply to a communication from the examining division
	12.05.2009	Despatch of a communication from the examining division (Time limit: M06)
	07.11.2009	Reply to a communication from the examining division
	22.05.2013	Communication of intention to grant the patent
	02.10.2013	Application deemed to be withdrawn, date of legal effect [2014/13]
	08.11.2013	Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2014/13]
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 21.07.2008
Fees paid	Renewal fee
	30.06.2004	Renewal fee patent year 03
	30.06.2005	Renewal fee patent year 04
	30.06.2006	Renewal fee patent year 05
	02.07.2007	Renewal fee patent year 06
	30.06.2008	Renewal fee patent year 07
	30.06.2009	Renewal fee patent year 08
	30.06.2010	Renewal fee patent year 09
	13.06.2011	Renewal fee patent year 10
	24.05.2012	Renewal fee patent year 11
	10.06.2013	Renewal fee patent year 12
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[Y]WO9823613 (PFIZER [US], et al) [Y] 1-25 * claims 1-27 *;
		[Y]WO9965908 (PFIZER PROD INC [US], et al) [Y] 1-25 * claims 1-12 *;
		[Y]WO9965909 (PFIZER PROD INC [US], et al) [Y] 1-25 * claims 1-10 *;
		[Y]WO0017202 (BASF AG [DE], et al) [Y] 1-25 * claims 1-45 *;
		[Y]US6140317 (TRAXLER PETER [CH], et al) [Y] 1-25 * claims 1-13 *;
		[Y]WO0142246 (PFIZER PROD INC [US], et al) [Y] 1-25 * claims 1-26 *;
		[A] - D. BERGSTROM ET AL., "Palladium-mediated synthesis of C-5 pyrimidine nucleoside thioethers from disulfides and mercurinucleosides", J. ORG. CHEM., (1991), vol. 56, no. 19, pages 5598 - 5602, XP002214295 [A] 1-25 * Scheme III * DOI: http://dx.doi.org/10.1021/jo00019a025

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p